What is VISTEON CORPORATION's earnings per share (EPS)?

VISTEON CORPORATION (VC) reported diluted earnings per share of $7.28 for fiscal year 2025. This represents a -31.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

VISTEON CORPORATION (VC) Financials

Trailing 12 months to June 30, 2026

Revenue $3.8B -1.1% YoY

Net Income $143.0M -52.8% YoY

EPS (Diluted) $5.21 -52.3% YoY

Operating Cash Flow $288.0M -38.2% YoY

Market Cap $2.3B as of Oct 8, 2026

Price / Sales 0.6x on $3.8B revenue, trailing 12 months to June 30, 2026

Price / Earnings 16.1x on $143.0M net income, trailing 12 months to June 30, 2026

Price / Book 1.4x on $1.6B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 23, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the VC SEC filings page.

VISTEON CORPORATION (VC) reported $3.8B in revenue over the twelve months to Jun 30, 2026, down 1.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI VC FY2025 2026-10-03

Visteon is becoming a higher-margin, cash-generating manufacturer even as sales remain below their FY2023 peak.

From FY2023 to FY2025, revenue fell 4.7% while gross profit stayed nearly flat as gross margin widened from 12.3% to 14.1%. That combination points to a more favorable cost or product mix, not growth being driven simply by selling more units.

Operating cash flow was $410M in FY2025 versus $427M in FY2024, nearly holding steady while revenue declined. The close cash-flow performance suggests the business converted its reported operating economics into cash without needing sales growth in this period, although free cash flow cannot be assessed because it is not reported.

Debt-to-equity fell from 0.7x in FY2021 to 0.2x in FY2025, reducing reliance on borrowed capital as equity increased. The current ratio also reached 1.8x, indicating short-term assets remained above short-term obligations; together, these measures describe a balance sheet that became less debt-dependent while maintaining working-capital coverage.

Financial Health Signals

Financial health score not available

VISTEON CORPORATION does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Strong

7/9

VISTEON CORPORATION passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

N/A

VISTEON CORPORATION reported $213 of net income while generating $410.0M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$960.0M

YoY-0.9%

QoQ+0.6%

5Y CAGR+9.5%

10Y CAGR+2.2%

VISTEON CORPORATION generated $960.0M in revenue in Q2 2026. This represents a decrease of 0.9% from the same quarter a year earlier. Against the prior quarter it is up 0.6%.

Net Income

$49.0M

YoY-31.0%

QoQ+58.1%

10Y CAGR+6.5%

VISTEON CORPORATION reported $49.0M in net income in Q2 2026. This represents a decrease of 31.0% from the same quarter a year earlier. Against the prior quarter it is up 58.1%.

EPS (Diluted)

$1.80

YoY-30.0%

QoQ+57.9%

10Y CAGR+9.0%

VISTEON CORPORATION earned $1.80 per diluted share (EPS) in Q2 2026. This represents a decrease of 30.0% from the same quarter a year earlier. Against the prior quarter it is up 57.9%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$648.0M

YoY-3.0%

QoQ-4.7%

5Y CAGR+6.8%

10Y CAGR-2.6%

VISTEON CORPORATION held $648.0M in cash against $284.0M in long-term debt as of Q2 2026.

Shares Outstanding

27M

YoY-2.1%

QoQ0.0%

5Y CAGR-0.9%

10Y CAGR-2.4%

VISTEON CORPORATION had 27M shares outstanding in Q2 2026. This represents a decrease of 2.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

12.3%

YoY-2.3pp

QoQ+0.4pp

5Y change+6.6pp

10Y change-1.8pp

VISTEON CORPORATION's gross margin was 12.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 2.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.4 percentage points.

Net Margin

5.1%

YoY-2.2pp

QoQ+1.8pp

5Y change+6.9pp

10Y change+1.7pp

VISTEON CORPORATION's net profit margin was 5.1% in Q2 2026, showing the share of revenue converted to profit. This is down 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.8 percentage points.

Return on Equity

3.0%

YoY-1.6pp

QoQ+1.0pp

5Y change+5.8pp

10Y change-1.2pp

VISTEON CORPORATION's ROE was 3.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$6.0M

QoQ-80.0%

VISTEON CORPORATION spent $6.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 80.0%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

VC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VC quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$3.8B	$3.8B-2.5%	$3.9B-2.2%	$4.0B+5.3%	$3.8B+35.4%	$2.8B+8.8%	$2.5B-13.5%	$2.9B-1.3%	$3.0B-5.1%	$3.1B-0.5%	$3.2B-2.6%	$3.2B+25.5%	$2.6B-65.2%	$7.4B+8.5%	$6.9B-9.0%	$7.5B
Cost of Revenue	$3.3B	$3.2B-3.0%	$3.3B-3.8%	$3.5B+2.3%	$3.4B+34.5%	$2.5B+9.4%	$2.3B-12.1%	$2.6B+1.9%	$2.6B-3.1%	$2.7B-1.8%	$2.7B-3.9%	$2.8B+25.3%	$2.2B+46.9%	$1.5B+4.2%	$1.5B-78.8%	$6.9B
Gross Profit	$484.0M	$532.0M+0.2%	$531.0M+9.0%	$487.0M+32.3%	$368.0M+44.9%	$254.0M+3.7%	$245.0M-24.4%	$324.0M-21.2%	$411.0M-16.3%	$491.0M+7.7%	$456.0M+6.0%	$430.0M+26.5%	$340.0M+74.4%	$195.0M+24.2%	$157.0M-74.6%	$618.0M
R&D Expenses	N/A	$220.0M+15.2%	$191.0M-9.0%	$210.0M+7.1%	$196.0M+2.6%	$191.0M-5.0%	$201.0M-33.0%	$300.0M+4.9%	$286.0M+13.0%	$253.0M-14.2%	$295.0M+0.3%	$294.0M+14.4%	$257.0M+73.6%	$148.0M+7.2%	$138.0M-57.7%	$326.0M
SG&A Expenses	$207.0M	$202.0M-2.4%	$207.0M0.0%	$207.0M+10.1%	$188.0M+7.4%	$175.0M-9.3%	$193.0M-12.7%	$221.0M+14.5%	$193.0M-14.6%	$226.0M+0.9%	$224.0M-8.6%	$245.0M+7.5%	$228.0M+30.3%	$175.0M-1.1%	$177.0M-54.3%	$387.0M
Interest Expense	$11.0M	$13.0M-13.3%	$15.0M-11.8%	$17.0M+21.4%	$14.0M+40.0%	$10.0M-37.5%	$16.0M+23.1%	$13.0M-7.1%	$14.0M-33.3%	$21.0M+16.7%	$18.0M-5.3%	$19.0M-24.0%	$25.0M-30.6%	$36.0M-18.2%	$44.0M-8.3%	$48.0M
Income Tax	$119.0M	$125.0M+1662.5%	-$8.0M+97.6%	-$330.0M-833.3%	$45.0M+45.2%	$31.0M+10.7%	$28.0M+16.7%	$24.0M-44.2%	$43.0M-10.4%	$48.0M+60.0%	$30.0M+11.1%	$27.0M-15.6%	$32.0M-42.9%	$56.0M+43.6%	$39.0M-69.3%	$127.0M
Net Income	$143.0M	$213-30.4%	$306-47.9%	$587+351.5%	$130+160.0%	$50+100.0%	-$56.0M-180.0%	$70.0M-57.3%	$164.0M-6.8%	$176.0M+134.7%	$75.0M-96.7%	$2.3B+874.2%	-$295.0M-142.8%	$690.0M+590.0%	$100.0M+25.0%	$80.0M
EPS (Basic)	N/A	$7.39-31.1%	$10.72-47.0%	$20.21+358.3%	$4.41+202.1%	$1.46+172.6%	-$2.01-180.7%	$2.49-55.2%	$5.56-0.2%	$5.57+160.3%	$2.14-96.0%	$54.00+938.5%	-$6.44-146.7%	$13.80+630.2%	$1.89+21.2%	$1.56
EPS (Diluted)	$5.21	$7.28-31.4%	$10.61-46.8%	$19.93+358.2%	$4.35+202.1%	$1.44	-$2.01-181.0%	$2.48-55.1%	$5.52+0.9%	$5.47+158.0%	$2.12-96.0%	$52.63+917.2%	-$6.44-147.7%	$13.50+618.1%	$1.88+22.1%	$1.54
Diluted Shares (Avg)	N/A	28M-1.1%	28M-2.1%	29M0.0%	29M+0.4%	28M	28M-1.1%	28M-5.1%	30M-7.8%	32M-9.0%	35M-18.4%	43M-5.2%	46M-10.4%	51M-4.1%	53M+2.5%	52M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$960.0M-0.9%	$954.0M+2.1%	$948.0M+1.0%	$917.0M-6.4%	$969.0M-4.4%	$934.0M+0.1%	$939.0M-5.2%	$980.0M-3.4%
Cost of Revenue	$842.0M+1.7%	$841.0M+5.7%	$826.0M+2.6%	$786.0M-7.4%	$828.0M-4.5%	$796.0M-2.2%	$805.0M-6.4%	$849.0M-2.5%
Gross Profit	$118.0M-16.3%	$113.0M-18.1%	$122.0M-9.0%	$131.0M0.0%	$141.0M-4.1%	$138.0M+16.0%	$134.0M+3.1%	$131.0M-8.4%
SG&A Expenses	$46.0M-4.2%	$54.0M+14.9%	$54.0M-1.8%	$53.0M+3.9%	$48.0M-2.0%	$47.0M-9.6%	$55.0M+7.8%	$51.0M-1.9%
Interest Expense	$2.0M-50.0%	$3.0M0.0%	$3.0M0.0%	$3.0M-25.0%	$4.0M0.0%	$3.0M-25.0%	$3.0M-25.0%	$4.0M0.0%
Income Tax	$26.0M+18.2%	$16.0M-38.5%	-$13.0M+70.5%	$90.0M+800.0%	$22.0M+69.2%	$26.0M+100.0%	-$44.0M+88.4%	$10.0M-52.4%
Net Income	$49.0M-31.0%	$31.0M-53.7%	$74.0M-40.8%	-$11.0M-127.5%	$71.0M-14.5%	$67.0M+39.6%	$125.0M+204.2%	$40.0M-39.4%
EPS (Basic)	$1.84-29.2%	$1.16-52.8%	$2.73-40.0%	-$0.40-127.6%	$2.60-13.6%	$2.46+41.4%	$4.55-65.1%	$1.45-38.3%
EPS (Diluted)	$1.80-30.0%	$1.14-53.3%	$2.67-40.4%	-$0.40-128.0%	$2.57-13.5%	$2.44+42.7%	$4.48-65.1%	$1.43-38.4%
Diluted Shares (Avg)	27M-1.4%	27M-0.7%	N/A	28M0.0%	28M-1.1%	28M-1.8%	N/A	28M-2.1%

Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA.

VC Balance Sheet

VC quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$3.4B+14.2%	$3.0B+8.8%	$2.7B+11.3%	$2.5B+9.7%	$2.2B-1.6%	$2.3B0.0%	$2.3B+13.2%	$2.0B-12.9%	$2.3B-2.9%	$2.4B-49.3%	$4.7B-12.1%	$5.3B-11.7%	$6.0B+16.9%	$5.2B+3.8%	$5.0B
Current Assets	$1.8B+11.8%	$1.6B-1.2%	$1.6B-5.5%	$1.7B+20.1%	$1.4B+6.2%	$1.3B-0.3%	$1.3B+3.8%	$1.3B-19.2%	$1.6B-6.1%	$1.7B-57.9%	$4.1B+29.3%	$3.1B-16.5%	$3.8B+40.9%	$2.7B+7.0%	$2.5B
Cash & Equivalents	$771.0M+23.8%	$623.0M+21.0%	$515.0M-1.0%	$520.0M+15.0%	$452.0M-8.9%	$496.0M+6.4%	$466.0M+0.6%	$463.0M-34.4%	$706.0M-19.6%	$878.0M-67.8%	$2.7B+473.1%	$476.0M-63.9%	$1.3B+59.8%	$825.0M+14.1%	$723.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$47.0M	$0	$0	$0	$0
Inventory	$269.0M-4.9%	$283.0M-5.0%	$298.0M-14.4%	$348.0M+32.8%	$262.0M+48.0%	$177.0M+4.7%	$169.0M-8.2%	$184.0M-2.6%	$189.0M+25.2%	$151.0M-19.3%	$187.0M-10.1%	$208.0M+60.0%	$130.0M-66.2%	$385.0M+1.0%	$381.0M
Accounts Receivable	$613.0M+6.1%	$578.0M-13.2%	$666.0M-0.9%	$672.0M+22.4%	$549.0M+13.4%	$484.0M-5.8%	$514.0M+5.8%	$486.0M-8.3%	$530.0M+5.0%	$505.0M+0.6%	$502.0M-5.5%	$531.0M+107.4%	$256.0M-78.0%	$1.2B+8.5%	$1.1B
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$47.0M+4.4%	$45.0M+12.5%	$40.0M-13.0%	$46.0M-9.8%	$51.0M+10.9%	$46.0M+27.8%	$36.0M
Total Liabilities	$1.8B+11.3%	$1.6B-3.3%	$1.7B-4.8%	$1.8B+3.3%	$1.7B-8.8%	$1.9B+5.2%	$1.8B+16.1%	$1.5B-7.5%	$1.7B-6.7%	$1.8B-50.7%	$3.6B-18.7%	$4.5B+8.5%	$4.1B+8.9%	$3.8B+3.0%	$3.7B
Current Liabilities	$992.0M+8.3%	$916.0M-1.6%	$931.0M-10.0%	$1.0B+21.5%	$852.0M+3.4%	$824.0M+3.3%	$798.0M+10.7%	$721.0M-10.0%	$801.0M-12.1%	$911.0M-67.1%	$2.8B+51.3%	$1.8B+1.7%	$1.8B+16.1%	$1.6B-0.1%	$1.6B
Non-Current Liabilities	$826.0M+15.2%	$717.0M-5.4%	$758.0M+2.4%	$740.0M-14.5%	$866.0M-18.3%	$1.1B+6.7%	$993.0M+21.0%	$821.0M-5.2%	$866.0M-1.1%	$876.0M+2.8%	$852.0M-67.6%	$2.6B+13.9%	$2.3B+3.9%	$2.2B+5.2%	$2.1B
Long-Term Debt	$283.0M-6.0%	$301.0M-5.3%	$318.0M-5.4%	$336.0M-3.7%	$349.0M0.0%	$349.0M+0.3%	$348.0M0.0%	$348.0M+0.3%	$347.0M+0.3%	$346.0M0.0%	$346.0M-41.1%	$587.0M+47.5%	$398.0M-15.9%	$473.0M-7.6%	$512.0M
Total Equity	$1.6B+17.6%	$1.3B+28.4%	$1.0B+53.8%	$675.0M+30.8%	$516.0M+33.3%	$387.0M-19.4%	$480.0M+3.2%	$465.0M-27.0%	$637.0M+8.7%	$586.0M-44.6%	$1.1B+22.2%	$865.0M-54.9%	$1.9B+38.6%	$1.4B+6.0%	$1.3B
Retained Earnings	$2.8B+7.0%	$2.7B+16.6%	$2.3B+27.2%	$1.8B+7.5%	$1.7B+2.5%	$1.6B-3.3%	$1.7B+4.4%	$1.6B+11.3%	$1.4B+13.9%	$1.3B+6.3%	$1.2B+80.6%	$661.0M-30.9%	$956.0M+259.4%	$266.0M+60.2%	$166.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$3.5B+4.6%	$3.4B+10.3%	$3.4B+14.2%	$3.3B+10.2%	$3.3B+16.7%	$3.1B+9.8%	$3.0B+8.8%	$3.0B+27.0%
Current Assets	$1.8B+4.6%	$1.8B+7.3%	$1.8B+11.8%	$1.8B+4.5%	$1.7B+5.0%	$1.7B+4.1%	$1.6B-1.2%	$1.7B+4.9%
Cash & Equivalents	$648.0M-3.0%	$680.0M+3.8%	$771.0M+23.8%	$762.0M+38.5%	$668.0M+32.3%	$655.0M+30.0%	$623.0M+21.0%	$550.0M+14.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$328.0M+10.8%	$316.0M+1.9%	$269.0M-4.9%	$313.0M-2.5%	$296.0M-4.8%	$310.0M-9.4%	$283.0M-5.0%	$321.0M+0.9%
Accounts Receivable	$666.0M+7.2%	$675.0M+10.1%	$613.0M+6.1%	$574.0M-20.2%	$621.0M-10.6%	$613.0M-6.0%	$578.0M-13.2%	$719.0M+5.9%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	$29.0M-17.1%	$31.0M	$34.0M	N/A	$35.0M
Total Liabilities	$1.8B+4.2%	$1.9B+10.9%	$1.8B+11.3%	$1.8B+3.7%	$1.8B+9.4%	$1.7B-0.4%	$1.6B-3.3%	$1.7B+4.6%
Current Liabilities	$1.0B+10.2%	$1.1B+13.6%	$992.0M+8.3%	$941.0M+0.4%	$921.0M+3.8%	$927.0M-1.2%	$916.0M-1.6%	$937.0M-1.2%
Non-Current Liabilities	$830.0M-2.2%	$814.0M+7.5%	$826.0M+15.2%	$830.0M+7.7%	$849.0M+16.1%	$757.0M+0.7%	$717.0M-5.4%	$771.0M+12.6%
Long-Term Debt	$284.0M-2.7%	$279.0M-6.1%	$283.0M-6.0%	$288.0M-5.9%	$292.0M-5.5%	$297.0M-5.4%	$301.0M-5.3%	$306.0M-5.3%
Total Equity	$1.6B+5.0%	$1.6B+9.7%	$1.6B+17.6%	$1.5B+18.7%	$1.5B+26.5%	$1.4B+24.8%	$1.3B+28.4%	$1.3B+77.6%
Retained Earnings	$2.9B+3.8%	$2.9B+5.1%	$2.8B+7.0%	$2.8B+9.7%	$2.8B+12.2%	$2.7B+13.1%	$2.7B+16.6%	$2.5B+32.4%

VC Cash Flow Statement

VC quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$288.0M	$410.0M-4.0%	$427.0M+59.9%	$267.0M+59.9%	$167.0M+187.9%	$58.0M-65.5%	$168.0M-8.2%	$183.0M-10.3%	$204.0M-5.1%	$215.0M+85.3%	$116.0M-65.7%	$338.0M+19.0%	$284.0M-9.0%	$312.0M+30.5%	$239.0M+36.6%	$175.0M
Depreciation & Amortization	N/A	$109.0M+13.5%	$96.0M-7.7%	$104.0M-3.7%	$108.0M0.0%	$108.0M+3.8%	$104.0M+4.0%	$100.0M+9.9%	$91.0M+4.6%	$87.0M+3.6%	$84.0M-50.3%	$169.0M-37.4%	$270.0M+3.1%	$262.0M+1.2%	$259.0M-18.0%	$316.0M
Stock-Based Compensation	N/A	$45.0M+9.8%	$41.0M+20.6%	$34.0M+30.8%	$26.0M+44.4%	$18.0M0.0%	$18.0M+5.9%	$17.0M+112.5%	$8.0M-33.3%	$12.0M+50.0%	$8.0M0.0%	$8.0M0.0%	$8.0M-46.7%	$15.0M-40.0%	$25.0M-35.9%	$39.0M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$142.0M+11.8%	$127.0M+28.3%	$99.0M+32.0%	$75.0M-59.9%	$187.0M-45.0%	$340.0M+26.4%	$269.0M+17.5%	$229.0M-11.2%	$258.0M
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$41.0M-46.8%	$77.0M-33.6%	$116.0M+182.9%	$41.0M-72.8%	$151.0M+369.6%	-$56.0M-230.2%	$43.0M+330.0%	$10.0M+112.0%	-$83.0M
Investing Cash Flow	-$159.0M	-$181.0M+4.2%	-$189.0M-53.7%	-$123.0M-80.9%	-$68.0M-7.9%	-$63.0M+35.7%	-$98.0M+23.4%	-$128.0M-30.6%	-$98.0M+43.4%	-$173.0M-157.3%	$302.0M-87.2%	$2.4B+418.6%	-$740.0M-206.0%	$698.0M+1845.0%	-$40.0M+87.9%	-$331.0M
Financing Cash Flow	-$155.0M	-$116.0M-16.0%	-$100.0M+35.9%	-$156.0M-1633.3%	-$9.0M+69.0%	-$29.0M+50.0%	-$58.0M-18.4%	-$49.0M+85.4%	-$335.0M-43.2%	-$234.0M+89.7%	-$2.3B-192.2%	-$774.0M-115.6%	-$359.0M-154.6%	-$141.0M-22.6%	-$115.0M-3733.3%	-$3.0M
Dividends Paid	$35.0M	$15.0M	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0	$0
Share Buybacks	$86.0M	$57.0M-9.5%	$63.0M-41.1%	$107.0M	$0	$0-100.0%	$16.0M-20.0%	$20.0M-93.3%	$300.0M+50.0%	$200.0M-60.0%	$500.0M0.0%	$500.0M0.0%	$500.0M+100.0%	$250.0M+400.0%	$50.0M	$0

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$37.0M-61.1%	$6.0M-91.4%	$118.0M-41.9%	$127.0M+29.6%	$95.0M+66.7%	$70.0M+1.4%	$203.0M+107.1%	$98.0M-22.8%
Depreciation & Amortization	$29.0M+7.4%	$29.0M+16.0%	$29.0M+16.0%	$28.0M+12.0%	$27.0M+12.5%	$25.0M+13.6%	$25.0M0.0%	$25.0M+4.2%
Stock-Based Compensation	$12.0M0.0%	$12.0M+9.1%	N/A	$11.0M+10.0%	$12.0M+9.1%	$11.0M+10.0%	N/A	$10.0M
Investing Cash Flow	-$45.0M+45.1%	-$48.0M-45.5%	-$45.0M-9.8%	-$21.0M+72.4%	-$82.0M-134.3%	-$33.0M+10.8%	-$41.0M+4.7%	-$76.0M-145.2%
Financing Cash Flow	-$30.0M-50.0%	-$47.0M-161.1%	-$64.0M-6.7%	-$14.0M-250.0%	-$20.0M-300.0%	-$18.0M+41.9%	-$60.0M-62.2%	-$4.0M+93.5%
Dividends Paid	$10.0M	$10.0M	$7.0M	$8.0M	$0	$0	$0	N/A
Share Buybacks	$6.0M	$30.0M+328.6%	$50.0M+16.3%	$0	$0-100.0%	$7.0M-65.0%	$43.0M+38.7%	$0-100.0%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

VC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VC quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	14.1%+0.4pp	13.7%+1.4pp	12.3%+2.5pp	9.8%+0.6pp	9.2%-0.5pp	9.6%-1.4pp	11.0%-2.8pp	13.8%-1.8pp	15.6%+1.2pp	14.4%+1.2pp	13.3%+0.1pp	13.2%+10.5pp	2.6%+0.3pp	2.3%-5.9pp	8.2%
Net Margin	0.0%0.0pp	0.0%0.0pp	0.0%0.0pp	0.0%0.0pp	0.0%+2.2pp	-2.2%-4.6pp	2.4%-3.1pp	5.5%-0.1pp	5.6%+3.2pp	2.4%-68.0pp	70.4%+81.8pp	-11.4%-20.7pp	9.3%+7.8pp	1.5%+0.4pp	1.1%
Return on Equity	0.0%0.0pp	0.0%0.0pp	0.0%0.0pp	0.0%0.0pp	0.0%+14.5pp	-14.5%-29.0pp	14.6%-20.7pp	35.3%+7.6pp	27.6%+14.8pp	12.8%-203.3pp	216.1%+250.2pp	-34.1%-70.0pp	35.9%+28.7pp	7.2%+1.1pp	6.1%
Return on Assets	0.0%0.0pp	0.0%0.0pp	0.0%0.0pp	0.0%0.0pp	0.0%+2.5pp	-2.5%-5.5pp	3.1%-5.1pp	8.2%+0.5pp	7.6%+4.5pp	3.2%-45.6pp	48.8%+54.3pp	-5.5%-17.0pp	11.5%+9.5pp	1.9%+0.3pp	1.6%
Current Ratio	1.80+0.1x	1.740.0x	1.74+0.1x	1.650.0x	1.670.0x	1.63-0.1x	1.69-0.1x	1.80-0.2x	2.00+0.1x	1.87+0.4x	1.46-0.2x	1.71-0.4x	2.08+0.4x	1.72+0.1x	1.60
Debt-to-Equity	0.180.0x	0.23-0.1x	0.31-0.2x	0.50-0.2x	0.68-0.2x	0.90+0.2x	0.720.0x	0.75+0.2x	0.540.0x	0.59+0.3x	0.33-0.4x	0.68+0.5x	0.21-0.1x	0.34-0.1x	0.39
Asset Turnover	1.11-0.2x	1.30-0.1x	1.45-0.1x	1.53+0.3x	1.24+0.1x	1.12-0.2x	1.30-0.2x	1.49+0.1x	1.370.0x	1.33+0.6x	0.69+0.2x	0.49-0.7x	1.23-0.1x	1.33-0.2x	1.52
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	1.4%-1.2pp	2.6%-1.1pp	3.7%+2.4pp	1.3%-3.4pp	4.7%+6.8pp	-2.2%-2.8pp	0.6%+0.4pp	0.1%+1.3pp	-1.1%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	12.3%-2.3pp	11.8%-2.9pp	12.9%-1.4pp	14.3%+0.9pp	14.5%+0.1pp	14.8%+2.0pp	14.3%+1.1pp	13.4%-0.7pp
Net Margin	5.1%-2.2pp	3.3%-3.9pp	7.8%-5.5pp	-1.2%-5.3pp	7.3%-0.9pp	7.2%+2.0pp	13.3%+25.4pp	4.1%-2.4pp
Return on Equity	3.0%-1.6pp	2.0%-2.7pp	4.7%-4.7pp	-0.7%-3.8pp	4.6%-2.2pp	4.7%+0.5pp	9.4%+20.9pp	3.1%-6.0pp
Return on Assets	1.4%-0.7pp	0.9%-1.3pp	2.2%-2.0pp	-0.3%-1.7pp	2.1%-0.8pp	2.2%+0.5pp	4.2%+8.6pp	1.3%-1.5pp
Current Ratio	1.78-0.1x	1.73-0.1x	1.80+0.1x	1.89+0.1x	1.870.0x	1.83+0.1x	1.740.0x	1.82+0.1x
Debt-to-Equity	0.180.0x	0.180.0x	0.180.0x	0.190.0x	0.19-0.1x	0.21-0.1x	0.23-0.1x	0.24-0.2x
Asset Turnover	0.280.0x	0.280.0x	0.280.0x	0.280.0x	0.29-0.1x	0.300.0x	0.320.0x	0.33-0.1x

Not reported in any period shown, so not listed: Operating Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
VISTEON CORPORATION VC	FY2025	$3.8B	$213	0.0%	$2.3B	—
Atmus Filtration Technologies Inc. ATMU	FY2025	$1.8B	$207.4M	11.8%	$3.6B	66/100
Hesai Group HSAI	FY2025	$432.9M	$62.3M	14.4%	$2.5B	57/100
ADVANCE AUTO PARTS INC AAP	FY2025	$8.6B	$44.0M	0.5%	$2.5B	29/100
Garrett Motion Inc. GTX	FY2025	$3.6B	$310.0M	8.6%	$4.8B	17/100
Goodyear Tire & Rubber GT	FY2025	$18.3B	-$1.7B	-9.4%	$1.4B	16/100

Where VISTEON CORPORATION Ranks

Frequently Asked Questions

What is VISTEON CORPORATION's annual revenue?

VISTEON CORPORATION (VC) reported $3.8B in total revenue for fiscal year 2025. This represents a -2.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is VISTEON CORPORATION's revenue growing?

VISTEON CORPORATION (VC) revenue declined by 2.5% year-over-year, from $3.9B to $3.8B in fiscal year 2025.

Is VISTEON CORPORATION profitable?

Yes, VISTEON CORPORATION (VC) reported a net income of $213 in fiscal year 2025, with a net profit margin of 0.0%.

How much debt does VISTEON CORPORATION have?

As of fiscal year 2025, VISTEON CORPORATION (VC) had $771.0M in cash and equivalents against $283.0M in long-term debt.

What is VISTEON CORPORATION's gross margin?

VISTEON CORPORATION (VC) had a gross margin of 14.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is VISTEON CORPORATION's net profit margin?

VISTEON CORPORATION (VC) had a net profit margin of 0.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does VISTEON CORPORATION pay dividends?

Yes, VISTEON CORPORATION (VC) paid $0.38 per share in dividends during fiscal year 2025.

What is VISTEON CORPORATION's return on equity (ROE)?

VISTEON CORPORATION (VC) has a return on equity of 0.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is VISTEON CORPORATION's operating cash flow?

VISTEON CORPORATION (VC) generated $410.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are VISTEON CORPORATION's total assets?

VISTEON CORPORATION (VC) had $3.4B in total assets as of fiscal year 2025, including both current and long-term assets.

How much does VISTEON CORPORATION spend on research and development?

VISTEON CORPORATION (VC) invested $220.0M in research and development during fiscal year 2025.

Does VISTEON CORPORATION buy back shares?

Yes, VISTEON CORPORATION (VC) spent $57.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does VISTEON CORPORATION have outstanding?

VISTEON CORPORATION (VC) had 27M shares outstanding as of fiscal year 2025.

What is VISTEON CORPORATION's current ratio?

VISTEON CORPORATION (VC) had a current ratio of 1.80 as of fiscal year 2025, which is generally considered healthy.

What is VISTEON CORPORATION's debt-to-equity ratio?

VISTEON CORPORATION (VC) had a debt-to-equity ratio of 0.18 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is VISTEON CORPORATION's return on assets (ROA)?

VISTEON CORPORATION (VC) had a return on assets of 0.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is VISTEON CORPORATION's P/E ratio?

VISTEON CORPORATION (VC) trades at 16.1x earnings, its market capitalization divided by net income of $143.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.3B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is VISTEON CORPORATION's price-to-sales ratio?

VISTEON CORPORATION (VC) trades at 0.6x sales, its market capitalization divided by revenue of $3.8B revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.3B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is VISTEON CORPORATION's Piotroski F-Score?

VISTEON CORPORATION (VC) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are VISTEON CORPORATION's earnings high quality?

VISTEON CORPORATION (VC) reported $213 of net income while generating $410.0M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.